End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
24.21 CNY | -0.66% | -2.34% | +41.50% |
May. 13 | Lingrui Pharma Gets Green Light to Market Type 2 Diabetes Drug | MT |
Apr. 25 | Henan Lingrui Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Official Publications
No official publication found
- Stock Market
- Equities
- 600285 Stock
- News Henan Lingrui Pharmaceutical Co., Ltd.
- Official Publications